your market intelligence analyst
Search Results
Edit Save
1,420 results 07/14/2020 11:11
Hao Tian Development Group Limited (HKEX Stock Code: 0474, "Hao Tian Development" or "the Group") a diversified investment holding company, through its subsidiary Aceso Life Sciences Holding Limited ("Aceso"), and Promethera Biosciences S.A./N.V. ("Promethera") today announced that the companies have entered into an agreement to form a joint venture ("Joint Venture Company"). 07/14/2020 10:34
Nokia (NYSE:NOK) announced today the availability of a software based upgrade that will enable its 4G/LTE radios to be migrated seamlessly to 5G/NR. These features will have a high value to Nokia’s customers as they provide immediate support for approximately one million radios, reaching 3.1 million by the end of the year and over 5 […]. . 07/14/2020 10:19
Dewpoint Therapeutics, the biomolecular condensates company, announced today that it has forged an exclusive collaboration agreement with Merck (NYSE:MRK), known as MSD outside the United States and Canada, to apply Dewpoint’s proprietary platform for condensate-based drug discovery to the development of a novel mechanism for the treatment of HIV. 07/14/2020 04:53
July 14, 2020 – Showa Denko (SDK; TSE:4004) has developed wet-resistant heat-conductive aluminum nitride filler to be used as heat-radiation filler for semiconductor devices. SDK has started to offer samples of the aluminum nitride filler. In accordance with the development of semiconductor devices with more power, heat generated in semiconductor devices continues to increase. On the […]. . 07/14/2020 02:57
Further Miniaturization, Lighter Weight and Higher Output; Applicable to a Wide Range of Electric Vehicles; Aiming for Mass-production in the Next 24 Months Apollo Future Mobility Group Limited ("AFMG", the "Company" ; SEHK stock code: 860.HK; and together with its subsidiaries, the "Group") is pleased to announce that its subsidiary, GLM Co., Ltd ("GLM"), has [...]. . 07/13/2020 03:51
Software AG today announced it has been selected by Bega Cheese to provide its Cumulocity IoT solution to Bega Cheese to launch a new IoT service linking the company’s farmer suppliers, milk transport and storage, and processing facilities. The deal will see Software AG providing Bega Cheese with IoT solutions to provide real time data […]. . 07/13/2020 02:53
In view of the significant resurgence of Covid-19 cases in the recent week of 6-12 July, the Hong Kong Trade Development Council (HKTDC) has discussed with the Government over the weekend, and was advised that, given the latest epidemic situation and the Government re-imposing certain social distancing restrictions on public health grounds, the Book Fair, [...]. . 07/13/2020 01:34
Greenbriar Capital Corp. (TSXV: GRB) (OTC: GEBRF) ("Greenbriar") is very pleased to announce that Greenbriar has executed an initial Master Sales and Marketing Agreement with Keller Williams Forward Living and its CEO to market and sell each unit of its $400 Million, 1,000 unit Sage Ranch sustainable subdivision in Southern California upon approval by the [...]. . 07/10/2020 08:11
The Papuan Representative Office of the National Commission on Human Rights of the Republic of Indonesia (Komnas HAM) revealed the case of a civilian death in Asiki, Boven Digoel Regency, the victim named Marius Betera, on May 16th 2020. This comes after completing a field investigation in order to meet the demand made by an […]. . 07/10/2020 05:00
With the successive introduction of the "Opinions on Facilitating the Inheritance, Innovation and Development of Traditional Chinese Medicine (TCM)" in certain provinces in mainland China and the "Regulations on Traditional Chinese Medicine" proposed by the Beijing municipality (Drafted Regulations on TCM for Public Opinions), the TCM industry has embarked on a rapid development. 07/10/2020 02:02
Reinforcing status as world’s 3rd largest rubber glove producer, with plans to hike production capacity to 100,000 million pieces/year Sri Trang Gloves (Thailand) PCL (STGT) expressed full confidence in the positive response from investors on its first trading day on the Stock Exchange of Thailand (SET), with strong business potential unaffected by the COVID-19 pandemic. 07/09/2020 22:16
澳大利亞阿德萊德, 2020年7月9日 – (亞太商訊) – Avance Clinical在全球遠程線上獎頒獎典禮上榮獲由Frost & Sullivan 頒發的久負盛名的“2020亞太CRO市場領導力獎”,其是澳大利亞在CRO 生物技術方面領先的公司。 關於 Frost & Sullivan: “’Frost & Sullivan最佳實踐獎’是對在各自行業中表現出色的頂尖公司的肯定與表彰。獲獎者都是Frost & Sullivan公司分析師進行深入訪談、分析和全方位的二次調研後確定的。通常Frost & Sullivan公司分析師會對候選公司的收入、市場份額、產能和對行業的總體貢獻進行調研,以確定是否符合最佳實踐獎獲得者的要求。” 這是該公司獲得的首個Frost & Sullivan獎項,其在過去一年裡在亞太地區發展迅速。 Avance Clinical 的首席執行官 Yvonne Lungershausen稱讚了她的團隊——由來自澳大利亞和新西蘭的100多名臨床試驗專家組成。 “我們已經證明:始終注重贊助商的文化和靈活主動的策略讓我們每次都會脫穎而出,我們的業務回頭率高達75%。而這一點得到了Frost & Sullivan調研團隊的認可,整個Avance Clinical 團隊對此都感到非常自豪。” “澳大利亞成功地解決了COVID-19危機,目前已經開始進行臨床試驗。這一獎項進一步加強了生物技術界的認知,即這是一個早期階段的專家目標,在這裡他們可以迎頭趕上延誤的試驗進度。” “Avance Clinical是推進快速研究項目啟動方面的專家,通常能在6週內批准並啟動試驗。” Avance Clinical是一家澳資委託合同研究組織,20年以來一直為當地和國際藥物研發行. 07/09/2020 21:43
Metro Pacific Tollways Corp (MPTC), a subsidiary of Philippine-listed infrastructure conglomerate Metro Pacific Investment Corporation (PSE: MPI), is set to begin today the construction of two new segments of the CAVITEX C5 Link Expressway. The project is worth P8.8 billion. Segment 2, which has a project cost of P7 billion, is a 1.9-kilometer, 2×3 lane […]. . 07/09/2020 13:00
該協議是進行下一步臨床試驗的重要前提 AIM是該臨床試驗的研究合作者和資助者 AIM ImmunoTech (NYSE- American 交易代碼: AIM) 於今日宣布,其已與 Roswell Park綜合癌症中心簽訂臨床試驗協議(CTA), 以支持 Roswell Park對感染 COVID-19的癌症患者進行的1/2a期 Ampligen (rintaolimod)聯合干擾素alfa-2b的試驗,其是由 SARS-CoV-2冠狀病毒引起的疾病。臨床試驗的資金部分來自國家癌症研究所和AIM的撥款,以及Roswell Park的機構出資。 AIM ImmunoTech的首席執行官Thomas K. Equels發表意見時表示:“我們很高興能與領先的癌症研究中心Roswell Park合作,在癌症患者中測試作為COVID-19抗病毒整套治療方案的一部分的Ampligen 。基於臨床前研究,我們對這種新型致命病毒的早期有效治療的潛力感到備受鼓舞,特別是對於重症感染者或有死亡風險的癌症患者。我們期待著能有效利用這項重要的臨床試驗,如果成功的話,其有望用於其他高危和免疫功能受損的COVID-19癌症患者的Ampligen 測試。” “我們非常感謝AIM在這項研究中的參與和合作,這對感染COVID-19的癌症患者是一個重要的潛在治療方案,” Pawel Kalinski,醫學博士, 哲學博士表示,轉化研究副主席和Roswell Park分子治療和轉化研究的Rustum家族教授,也是世衛組織的該項新型臨床試驗以及其他五項相關研究的科研帶頭人。 “這項試驗是Roswell Park致力於優化治療癌症和傳染病的免疫方法的一個標誌性因素,AIM對我們願景的支持有助於確保我們能夠將這種新穎的. 07/09/2020 12:27
该协议是进行下一步临床试验的重要前提 AIM是该临床试验的研究合作者和资助者 AIM ImmunoTech (NYSE- American 交易代码: AIM)于今日宣布,其已与 Roswell Park综合癌症中心签订临床试验协议(CTA), 以支持 Roswell Park对感染 COVID-19的癌症患者进行的1/2a期 Ampligen (rintaolimod)联合干扰素alfa-2b的试验,其是由 SARS-CoV-2冠状病毒引起的疾病。临床试验的资金部分来自国家癌症研究所和 AIM的拨款,以及 Roswell Park的机构出资。 AIM ImmunoTech的首席执行官Thomas K. Equels发表意见时表示:“我们很高兴能与领先的癌症研究中心Roswell Park合作,在癌症患者中测试作为COVID-19抗病毒整套治疗方案的一部分的Ampligen 。基于临床前研究,我们对这种新型致命病毒的早期有效治疗的潜力感到备受鼓舞,特别是对于重症感染者或有死亡风险的癌症患者。我们期待着能有效利用这项重要的临床试验,如果成功的话,其有望用于其他高危和免疫功能受损的COVID-19癌症患者的Ampligen 测试。” “我们非常感谢AIM在这项研究中的参与和合作,这对感染COVID-19的癌症患者是一个重要的潜在治疗方案,” Pawel Kalinski,医学博士, 哲学博士表示,转化研究副主席和Roswell Park分子治疗和转化研究的Rustum家族教授,也是世卫组织的该项新型临床试验以及其他五项相关研究的科研带头人。“这项试验是Roswell Park致力于优化治疗癌症和传染病的免疫方法的一个标志性因素,AIM对我们愿景的支持有助于确保我们能够将这种新颖的. 07/09/2020 10:37
via NEWMEDIAWIRE — LIFEQUEST WORLD CORP (LQWC) subsidiary Biopipe Global, which has developed the world’s only highly scalable onsite sludge and chemical-free sewage wastewater treatment technology, has shipped its first plant to California. With a capacity of 10m3/day (2,640 gallons/day), the plant will be installed at a campground in Southern California. Enes Kutluca, the CEO […]. . 07/09/2020 04:49
Asia, July 9, 2020 – (ACN Newswire) – Yet again Clavent has brought HR leaders across the globe on a single platform to plant a flag on their first-ever virtual event “Emerge2020 HR Tech Summit” organized on 25-26th June. Amidst the pandemic, Clavent is always ready to Inspire, Interact, and Innovate. Certainly establishing norms of “virtual experience” in current […]. . 07/09/2020 04:16
SINGAPORE, July 8, 2020 – (ACN Newswire) – Frost & Sullivan honored Asia-Pacific’s leading companies at the 18th annual Asia-Pacific Best Practices Awards on 8 July in an inaugural virtual awards ceremony. A total of 15 awards were presented to organizations for elevating performance benchmarks and for their outstanding achievements in the industry. These awards […]. . 07/09/2020 02:49
Avance Clinical在全球远程线上奖颁奖典礼上荣获由Frost & Sullivan 颁发的久负盛名的“2020亚太CRO市场领导力奖”,其是澳大利亚在CRO 生物技术方面领先的公司。 关于 Frost & Sullivan: “‘Frost & Sullivan最佳实践奖’是对在各自行业中表现出色的顶尖公司的肯定与表彰。获奖者都是Frost & Sullivan公司分析师进行深入访谈、分析和全方位的二次调研后确定的。通常Frost & Sullivan公司分析师会对候选公司的收入、市场份额、产能和对行业的总体贡献进行调研,以确定是否符合最佳实践奖获得者的要求。” 这是该公司获得的首个Frost & Sullivan奖项,其在过去一年里在亚太地区发展迅速。 Avance Clinical 的首席执行官 Yvonne Lungershausen称赞了她的团队——由来自澳大利亚和新西兰的100多名临床试验专家组成。 “我们已经证明:始终注重赞助商的文化和灵活主动的策略让我们每次都会脱颖而出,我们的业务回头率高达75%。而这一点得到了Frost & Sullivan调研团队的认可,整个Avance Clinical 团队对此都感到非常自豪。” “澳大利亚成功地解决了COVID-19危机,目前已经开始进行临床试验。这一奖项进一步加强了生物技术界的认知,即这是一个早期阶段的专家目标,在这里他们可以迎头赶上延误的试验进度。” “Avance Clinical是推进快速研究项目启动方面的专家,通常能在6周内批准并启动试验。” Avance Clinical是一家澳资委托合同研究组织,20年以来一直为当地和国际药物研发行业提供符合全球监管标准的高质量临床研究服务。 Avance专注.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios